News DeepTechU Day 3: Navigating Lab to Launch, Deep Tech Investment, and a Culture Shift Toward Commercialization “The best companies we see have deep venture experience,” said Beckett Jackson, investing director, Boeing HorizonX. But they also have a grand vision about how the technology will become a...
Technology Fully Synthetic Adjuvant Delivery System For Enhanced Tumor-Targeted Immunotherapy A cancer vaccine that enhances immune response by directly binding adjuvants to tumor cells, avoiding targeting antibodies, and reducing related side effects The problem: Therapeutic vaccination has long been a…
News Life Sciences Community Convenes at Chicago BioCapital Summit in a Showcase of Local Innovation Hosted by the Chicago Biomedical Consortium (CBC), the inaugural Chicago BioCapital Summit this week brought together industry, academia, and investors in a showcase of the latest innovations in the life...
News ClostraBio Closes $4 Million Series A to Transform Intestinal Health with Plug-and-Play Drug Delivery Platform University of Chicago spinout ClostraBio has closed a $4 million Series A-1 financing round to accelerate development of its lead candidate, expand its plug-n-play platform, and build out its team....
News ISTC Releases 2020 R&D Index and Names Three UChicago Professors Top Researchers to Know The Illinois Science and Technology Coalition (ISTC) this week released its latest R&D Index – as well as this year’s Researchers to Know, which includes three faculty members from the...
News Meet the Investor: Jeffrey Stine, VestedWorld “We are very excited about what we call “tech-enabled” solutions, and Africa, in my view, is ground zero for these types of opportunities.” That is according to Jeffrey Stine, principal...
Technology Protein Engineering Strategy for Enhancing Healing Of Chronic Diabetic and Radiation-Induced Wounds The problem: Chronic, non‐healing wounds have reached epidemic proportions and have a sustainable impact on both an individual’s quality of life and on healthcare costs as a whole The field…
Technology Development Of A Novel Anti-fibrotic (siRNA Talin2) That Reverses Existing Fibrosis Fibrosis is involved in 45% of deaths in the United States, and no treatment exists to reverse the progression of the disease. Fibrosing diseases include pulmonary fibrosis, congestive heart failure,…
Technology RNA Editing Technology for Enhancing Tumor Immunogenicity and Immune Checkpoint Inhibitors Novel RNA editing method to generate a multitude of neoantigens in tumor cells making the cells more recognizable by T cells and enhancing the efficacy of immune checkpoint inhibitors The…
Technology Engineered Flt3L Variants For Antigen Tolerance Induction Engineered recombinant fusion of the dendritic cell growth factor Flt3L to serum albumin to modulate the antigen-presenting compartment and bias it toward tolerance particularly against therapeutic proteins. The Unmet Need:…
News Immunoengineering Conference to Highlight the Latest Developments in Industry, Academia, and UChicago Startups The Pritzker School of Molecular Engineering’s Chicago Immunoengineering Innovation Center (CIIC) in partnership with the Polsky Center for Entrepreneurship and Innovation is hosting Immunoengineering 2021 – which will highlight the...
Technology Next-Generation Immunotherapy Platform With Engineered Collagen-Binding Cytokine Combinations Combination engineered IL-7 and IL-12 proteins that target tumors by binding to collagen, boosting immune attack on cancer while reducing side effects and improving long-term protection, even in cancers resistant…
